SONM insider filings
DNA X, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-02-10. Screen SONM transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for SONM between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — DNA X, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-10 | 4 | Crolius Clayton — Chief Financial Officer | Grant/award (A): 35,000 @ $0 | EDGAR |
| 2026-02-10 | 4 | MULICA MICHAEL C — Acting CEO, Director | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2025-07-07 | 4 | LYTTON LAURENCE W — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2025-06-30 | 4 | LYTTON LAURENCE W — 10% owner | Sale (S): 466,402 @ $1.50 · Sale (S): 400,514 @ $1.39 | EDGAR |
| 2025-05-05 | 4 | LYTTON LAURENCE W — 10% owner | Holdings only — no transactions reported | EDGAR |
| 2025-04-25 | 4 | Wang Jeffrey — Director | Sale (S): 4,478 @ $1.45 | EDGAR |
| 2025-04-25 | 4 | Crolius Clayton — Chief Financial Officer | Sale (S): 11,634 @ $1.45 | EDGAR |
| 2025-04-25 | 4 | Steenstra Jack — Director | Sale (S): 23,381 @ $1.45 | EDGAR |
| 2025-04-25 | 4 | MULICA MICHAEL C — Director | Sale (S): 27,818 @ $1.45 | EDGAR |
| 2025-04-25 | 4 | Cassano James S — Director | Sale (S): 23,381 @ $1.45 | EDGAR |
| 2025-04-25 | 4 | Becher Charles — See Remarks | Sale (S): 31,326 @ $1.45 | EDGAR |
| 2025-04-02 | 4 | MULICA MICHAEL C — Director | Grant/award (A): 46,728 @ $0 | EDGAR |
| 2025-04-02 | 4 | Steenstra Jack — Director | Grant/award (A): 46,728 @ $0 | EDGAR |
| 2025-04-02 | 4 | Cassano James S — Director | Grant/award (A): 46,728 @ $0 | EDGAR |
| 2025-02-10 | 4 | Liu Hao Peter — Chief Executive Officer, Director | Grant/award (A): 63,604 @ $0 | EDGAR |
| 2025-02-10 | 4 | Crolius Clayton — Chief Financial Officer | Grant/award (A): 33,922 @ $0 | EDGAR |
| 2025-02-10 | 4 | Becher Charles — See Remarks | Grant/award (A): 70,671 @ $0 | EDGAR |
| 2024-11-14 | 4 | MULICA MICHAEL C — Director | Grant/award (A): 14,124 @ $0 · Sale (S): 2,559 @ $3.28 | EDGAR |
| 2024-07-23 | 4 | Steenstra Jack — Director | Sale (S): 1,623 @ $3.67 | EDGAR |
| 2024-07-23 | 4 | Cassano James S — Director | Sale (S): 1,623 @ $3.68 | EDGAR |
| 2024-07-23 | 4 | Wang Jeffrey — Director, 10% owner | Sale (S): 1,623 @ $3.67 | EDGAR |
| 2024-06-24 | 4 | MULICA MICHAEL C — Director | Grant/award (A): 78,947 @ $0 · Sale (S): 36,016 @ $0.69 | EDGAR |
| 2024-06-24 | 4 | Cassano James S — Director | Grant/award (A): 78,947 @ $0 · Sale (S): 36,015 @ $0.69 | EDGAR |
| 2024-06-24 | 4 | Steenstra Jack — Director | Grant/award (A): 78,947 @ $0 · Sale (S): 35,882 @ $0.69 | EDGAR |
| 2024-06-24 | 4 | Wang Jeffrey — Director, 10% owner | Grant/award (A): 78,947 @ $0 · Sale (S): 36,016 @ $0.69 | EDGAR |
| 2024-04-09 | 4 | Crolius Clayton — Chief Financial Officer | Grant/award (A): 170,000 (derivative) @ $0 | EDGAR |
| 2024-01-10 | 4 | MULICA MICHAEL C — Director | Grant/award (A): 66,675 @ $0 | EDGAR |
| 2023-12-28 | 4 | Becher Charles — See Remarks | Option exercise (M): 125,000 @ $0.42 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2023-11-27 | 4 | Crolius Clayton — Chief Financial Officer | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2023-09-29 | 4 | MULICA MICHAEL C — Director | Grant/award (A): 89,525 @ $0 | EDGAR |
| 2023-09-29 | 4 | Steenstra Jack — Director | Grant/award (A): 89,525 @ $0 | EDGAR |
| 2023-09-29 | 4 | Cassano James S — Director | Grant/award (A): 89,525 @ $0 | EDGAR |
| 2023-09-29 | 4 | Wang Jeffrey — Director, 10% owner | Grant/award (A): 89,525 @ $0 | EDGAR |
| 2023-09-18 | 4 | Crolius Clayton — Chief Financial Officer | Purchase (P): 86,700 @ $0.68 | EDGAR |
| 2023-08-23 | 4 | Liu Hao Peter — Chief Executive Officer, Director | Option exercise (M): 1,000,000 @ $0.42 · Option exercise (M): 1,000,000 (derivative) @ $0 | EDGAR |
| 2023-03-28 | 4 | Howe Alan B — Director | Purchase (P): 1,818 @ $0.60 | EDGAR |
| 2023-01-31 | 4 | Crolius Clayton — Chief Financial Officer | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2022-11-22 | 4 | Cassano James S — Director | Grant/award (A): 47,732 @ $0 | EDGAR |
| 2022-11-21 | 4 | Liu Hao Peter — Chief Executive Officer, Director | Grant/award (A): 4,014,419 (derivative) @ $0 | EDGAR |
| 2022-11-21 | 4 | Wang Jeffrey — Director, 10% owner | Grant/award (A): 47,732 @ $0 | EDGAR |
| 2022-11-21 | 4 | Principe Jose Carlos — Director | Grant/award (A): 47,732 @ $0 | EDGAR |
| 2022-11-21 | 4 | Howe Alan B — Director | Grant/award (A): 47,732 @ $0 | EDGAR |
| 2022-11-21 | 4 | MULICA MICHAEL C — Director | Grant/award (A): 47,732 @ $0 | EDGAR |
| 2022-11-21 | 4 | Steenstra Jack — Director | Grant/award (A): 47,732 @ $0 | EDGAR |
| 2022-10-14 | 4/A | Principe Jose Carlos — Director | Grant/award (A): 101,694 @ $0 | EDGAR |
| 2022-10-14 | 4/A | Cassano James S — Director | Grant/award (A): 93,823 @ $0 | EDGAR |
| 2022-10-14 | 4/A | Wang Jeffrey — Director, 10% owner | Grant/award (A): 93,823 @ $0 | EDGAR |
| 2022-10-14 | 4/A | Steenstra Jack — Director | Grant/award (A): 93,823 @ $0 | EDGAR |
| 2022-08-10 | 4 | AJP Holding Company, LLC — 10% owner | Purchase (P): 5,534,881 @ $0.84 | EDGAR |
| 2022-08-09 | 4 | Wang Jeffrey — Director, 10% owner | Grant/award (A): 85,714 @ $0 · Purchase (P): 5,534,881 @ $0.84 | EDGAR |
Recent 8-K events — DNA X, Inc.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-11-16 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-31 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-08-13 | 8-K/A | 3.02 — Unregistered Sales of Equity Securities 8.01 — Other Events | EDGAR |
| 2026-07-09 | 8-K/A | 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 8.01 — Other Events | EDGAR |
| 2026-07-02 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 3.03 — Material Modification to Rights of Security Holders 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-04 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-27 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-20 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-30 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=SONM returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs